IPO round-up: Lantheus plans $125m IPO; Intersect looks for $80m
This article was originally published in Clinica
Lantheus Holdings, the parent company of imaging agent specialist Lantheus Medical Imaging, is planning a $125m initial public offering. The company did not give details of how many shares it plans to sell or at what price. It hopes to list on the Nasdaq under the ticker symbol LNTH.